June 07, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
NEW ORLEANS —Use of automated insulin delivery during hospitalization may improve glycemic outcomes for adults with insulin-treated diabetes, according to data presented at the American Diabetes Association Scientific Sessions.In the AIDING randomized controlled trial, hospitalized adults with diabetes who used the Omnipod 5 (Insulet) automated insulin delivery system along with the Dexcom
June 07, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care

Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions

NEW ORLEANS — A next-generation automated insulin delivery algorithm was tied to improved glycemic outcomes compared with a…

NEW ORLEANS — In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and…

There is variation in how automated insulin delivery algorithms operate, and diabetes care and education specialists should be…

Children and adults with type 1 diabetes who used a fast-acting mealtime insulin along with automated insulin delivery had…

NEW ORLEANS — Adults with type 1 diabetes had a similar time in range using automated insulin delivery with ultrarapid-acting…

Youths who start using an automated insulin delivery system within 6 months of type 1 diabetes diagnosis are 82% more likely to…